Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyradiculoneuropathy, Chronic Inflammatory Demyelinating”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Large-scale testing (Phase 3)Looking for participantsNCT06714838
What this trial is testing

Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
CIDP
Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC) 100
Testing effectiveness (Phase 2)Looking for participantsNCT07032662
What this trial is testing

IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Immunovant Sciences GmbH 162
Not applicableLooking for participantsNCT06968975
What this trial is testing

Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

Who this might be right for
Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi 200
Not applicableEnded earlyNCT05614128
What this trial is testing

Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP

Who this might be right for
CIDP
Vanderbilt University Medical Center 2
Testing effectiveness (Phase 2)WithdrawnNCT02574962
What this trial is testing

Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Mamatha Pasnoor, MD
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Daishi Tian 36
Very early researchNot Yet RecruitingNCT06485232
What this trial is testing

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple Sclerosis+1 more
Xuanwu Hospital, Beijing 25
Not applicableNot Yet RecruitingNCT05219383
What this trial is testing

Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Assiut University 36
Testing effectiveness (Phase 2)Study completedNCT02967679
What this trial is testing

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyPeripheral NeuropathyCharcot-Marie-Tooth Disease+3 more
MedDay Pharmaceuticals SA 15
Large-scale testing (Phase 3)Study completedNCT00220740
What this trial is testing

Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Grifols Therapeutics LLC 117
Not applicableStudy completedNCT03008733
What this trial is testing

Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Centre Hospitalier Universitaire de Nice 36
Large-scale testing (Phase 3)Study completedNCT02027701
What this trial is testing

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
CSL Behring 82
Not applicableStudy completedNCT02111590
What this trial is testing

Immunoglobulin Dosage and Administration Form in CIDP and MMN

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyMultifocal Motor NeuropathyHemolytic Anemia
Rigshospitalet, Denmark 36
Not applicableLooking for participantsNCT07273903
What this trial is testing

Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices

Who this might be right for
CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Heinrich-Heine University, Duesseldorf 35
Testing effectiveness (Phase 2)Study completedNCT04281472
What this trial is testing

Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
argenx 322
Large-scale testing (Phase 3)Study completedNCT00004772
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Center for Research Resources (NCRR) 90
Large-scale testing (Phase 3)Study completedNCT02549170
What this trial is testing

HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Baxalta now part of Shire 138
Testing effectiveness (Phase 2)WithdrawnNCT01236456
What this trial is testing

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Stony Brook University
Large-scale testing (Phase 3)Study completedNCT06325943
What this trial is testing

Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Istituto Clinico Humanitas 37
Not applicableNo Longer AvailableNCT05014724
What this trial is testing

CIDP07 Rozanolixizumab Post Trial Access Program (the PTA)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
UCB Biopharma SRL
Load More Results